NCT02746263终止4 期
A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Repeated Dose, Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain in Combination With Patient-Controlled Analgesia With Morphine in Adults Following Elective Total Knee Arthroplasty
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- Mallinckrodt
- 入组人数
- 1
- 试验地点
- 2
- 主要终点
- Pain Intensity on a Numerical Pain Scale (NPS) for 18 Hours
研究概览
简要总结
The purpose of this study is to compare intravenous (IV) and oral acetaminophen for the treatment of acute moderate to severe pain in combination with standard patient-controlled analgesia (PCA) in adult subjects following total knee replacement.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 50 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject must be adequately informed and understand the nature and risks of the study and must be able to provide a signature and date on the informed consent form.
- •Subject must be male or females, between 50 and 90 years of age (inclusive) at Screening.
- •Subject must have a weight range of 50 to 120 kg.
- •Subject must be in a American Society of Anesthesiologists risk class of I, II, or III.
- •Subject must have successfully completed an unilateral uncomplicated total knee replacement surgery, able to take oral medication, and report having moderate to severe acute pain as determined by a pain score ≥ 5 from the 11-point Numeric Pain Rating Scale (NPRS) scale during the period of 3 to 6 hours postsurgery.
- •Female subjects of child-bearing potential must have a negative serum pregnancy test at the Screening and day-of-surgery.
- •Subjects must be able to communicate effectively with study personnel.
- •Subject must be able and willing to follow all protocol requirements, including operating a PCA device, and study restrictions.
排除标准
- •Subject is from a vulnerable population, as defined by the Code of Federal Regulations Title 45, Part 46,
- •Section 46.111(b), including but not limited to employees (temporary, part-time, full time, etc.) or a family member of the research staff conducting the study, or of the sponsor, or of the clinical research organization, or of the Institutional Review Board.
- •Subject has an oxygen saturation of less than 95% while awake on room air.
- •Subject has a positive test result for human immunodeficiency virus, hepatitis B (surface antigen), or hepatitis C virus antibody at Screening.
- •Subject has used an average of 30 mg oral morphine equivalents or greater, 1 to 2 weeks prior to the day of surgery. Subjects who, in the investigator's opinion are developing opioid tolerance will be excluded.
- •Subject has a history of any drug allergy, hypersensitivity, or intolerance to acetaminophen or morphine or to any of the excipients in the IV or oral formulations used.
- •Subject has intra- or postoperative complications, which in the view of the investigator, makes the subject unsuitable for the participation of the study.
- •Subject has received neuraxial (spinal or epidural) opioid injected perioperatively.
- •Subject has received a local anesthetic, regional, or wound injection or continuous infusion by any route.
- •Subject has impaired liver function (eg, aspartate aminotransferase, alanine aminotransferase, or bilirubin greater than or equal to 3.0 times the upper limit of normal), active hepatic disease, evidence of clinically significant liver disease, or other condition (eg, alcoholism, cirrhosis, or hepatitis) that suggests the potential for an increased susceptibility to hepatic toxicity with study drug exposure.
- •Subject has renal dysfunction or is at risk for renal failure due to volume depletion.
- •Subject has donated or had significant loss of whole blood (480 mL or more) within 30 days, or plasma within 14 days prior to dosing.
- •Subject has had any major surgery within 3 months prior to day-of-surgery.
- •Subject has a history of acute illness within 14 days prior to day-of-surgery.
- •Subject has participated in another clinical study within 30 days prior to day-of-surgery or plans to participate in another clinical study while concurrently enrolled in this study.
- •Subject has a history of conditions which might be specifically contraindicated or require caution to be used during the administration of any drug in the study.
- •Subject has any other medical, psychiatric and/or social reason for exclusion as determined by the investigator.
- •Subject has a positive test result for drugs of abuse (amphetamines, barbiturates, benzodiazepines, cannabinoids [including medical use of marijuana], cocaine, methamphetamine, methadone, or methylenedioxy-methamphetamine) at Screening. Subjects with a positive test result for prescribed drugs may be included in the study at the discretion of the investigator. Subjects with a positive test result for cannabinoids with a prescription for medical marijuana will be excluded from the study, subjects with a prescription for dronabinol (∆-9-tetrahydrocannabinol) may be included at the discretion of the investigator.
研究组 & 干预措施
IV acetaminophen/Morphine
Experimental
IV acetaminophen 1000 mg every 6 hours over 18 hours
干预措施: IV acetaminophen (Drug)
IV acetaminophen/Morphine
Experimental
IV acetaminophen 1000 mg every 6 hours over 18 hours
干预措施: Morphine (Drug)
Oral acetaminophen/Morphine
Active Comparator
Oral acetaminophen two 500 mg tablets every 6 hours over 18 hours
干预措施: Oral acetaminophen (Drug)
Oral acetaminophen/Morphine
Active Comparator
Oral acetaminophen two 500 mg tablets every 6 hours over 18 hours
干预措施: Morphine (Drug)
结局指标
主要结局
Pain Intensity on a Numerical Pain Scale (NPS) for 18 Hours
时间窗: 18 hours
Participants rate intensity of their pain on a Numerical Pain Scale (NPS) from 0-10, wherein 0=no pain (better) and 10=most intense pain (worse). The highest possible score is 10.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Efficacy of IV Acetaminophen Versus Oral AcetaminophenNephrectomyNCT03365622University of Rochester214
已完成
4 期
Efficacy of Oral vs. Intravenous AcetaminophenPostoperative PainNCT02643394University of Texas Southwestern Medical Center110
招募中
3 期
IV Acetaminophen After Cardiac Surgery - PILOTDeliriumNCT05246644McGill University Health Centre/Research Institute of the McGill University Health Centre900
已完成
4 期
Acetaminophen's Efficacy For Post-operative PainAirway ObstructionDifficulty SwallowingTonsillitisNCT01721486Kaveh Aslani, MD41
Enrolling By Invitation
4 期
A Study of Intravenous Acetaminophen for Small Bowel ObstructionSmall Bowel ObstructionNCT05878015Mayo Clinic18